Novel Therapeutic Agents for Resistant Gram-Positive Infections

By  

Current Drug Therapy, Vol. 3, Iss. 2, 2008-05 ,pp. : 98-110

Bentham Science Publishers

Access to resources Recommend Favorite

An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial

By Kyriakides T.C.   Babiker A.   Singer J.   Cameron W.   Schechter M.T.   Holodniy M.   Brown S.T.   Youle M.   Gazzard B.   on behalf of the OPTIMA Study Team see Appendix  

Controlled Clinical Trials, Vol. 24, Iss. 4, 2003-08 ,pp. : 481-500

Elsevier

Access to resources Recommend Favorite

Oxidized low-density lipoprotein autoantibodies in patients with primary gout: effect of urate-lowering therapy

By Tsutsumi Z.   Moriwaki Y.   Takahashi S.   Ka T.   Yamamoto T.  

Clinica Chimica Acta, Vol. 339, Iss. 1, 2004-01 ,pp. : 117-122

Elsevier

Access to resources Recommend Favorite

Recombinant Antibodies as Therapeutic Agents: Pathways for Modeling New Biodrugs

By Frederico Aires da Silva   Corte-Real Sofia   Goncalves Joao  

BioDrugs, Vol. 22, Iss. 5, 2008-01 ,pp. : 301-314

Adis International

Access to resources Recommend Favorite

Optimisation of the Treatment of Acute Gout

By Perez-Ruiz F.   Mielgo F.J.G.   Herrero Beites A.M.  

BioDrugs, Vol. 13, Iss. 6, 2000-06 ,pp. : 415-423

Adis International

Access to resources Recommend Favorite